This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Univerzita Karlova, Ustav Organicke Chemie a Biochemie Av Cr, V.v.i.. Active years: 2026.
Company Filing History:
1 out of 4 
1 out of 37 
Years Active: 2026
Title: Petr Pavek - Innovator in Pharmaceutical Chemistry
Introduction: Petr Pavek is an accomplished inventor based in Hradec Králové, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medicinal use. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical treatments.
Latest Patent Applications: Petr Pavek's latest patent applications include two significant inventions. The first is titled "Selective Ligands of Human Constitutive Androstane Receptor." This application discloses a structurally novel class of heterocyclic compounds that are useful in the prevention or treatment of conditions mediated by the action of the Constitutive Androstane Receptor (CAR). The second application is for "Substituted 1,2,4-Oxadiazole, Its Application and a Pharmaceutical Preparation Comprising It." This invention focuses on compounds effective against tuberculosis, characterized by low toxicity and high efficacy against mycobacteria, including multiresistant strains.
Conclusion: Petr Pavek's innovative work in pharmaceutical chemistry highlights his dedication to advancing medical science. His latest patent applications reflect his commitment to developing effective treatments for serious health conditions.